Lavo Life Sciences offers AI-powered crystal structure prediction to streamline drug development. By combining computational chemistry expertise with advanced AI, Lavo helps pharmaceutical teams de-risk pipelines, optimize solid-state formulations, and avoid late-stage surprises. This cutting-edge solution enables faster crystal form identification and improves drug stability and manufacturability.
Key Features:
Accurate crystal structure prediction for small molecule drugs.
AI-accelerated identification of novel polymorphs with enhanced properties.
Reduced risk of unexpected crystal forms disrupting drug development.
Optimization of solid-state formulations for stability and production.
Faster turnaround for crystal form identification and analysis.
Disclaimer: Please refer to the website for the most accurate and current pricing details and service offerings.
Best for:
Drug developers aiming to minimize risks in formulation design.
Pharmaceutical teams looking to accelerate solid-state research.
Companies seeking to optimize drug stability and manufacturability.
Researchers exploring novel polymorphs with unique properties.
Teams wanting to reduce time spent on crystal form identification.
Organizations prioritizing AI-driven insights for better decision-making.
Professionals focusing on de-risking pipelines for smooth drug development.
Lavo AI accelerates crystal structure predictions with impressive accuracy, helping drug developers avoid costly surprises. Its advanced AI optimizes formulations, boosting stability and speeding up research timelines effectively.